Multiple transactivation domains of EZH2 bind to the TAZ2 domain of p300 and stimulate the acetyltransferase function of p300
Biochemical Journal · 2025
DOI: 10.1042/bcj20253037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Journal, 2025. Verfasst von Dustin C Becht und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Colorado School of Medicine, Aurora CO 80045, U.S.A. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Transcriptional Activation, p300-CBP Transcription Factors, E1A-Associated p300 Protein. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
The H3K27me-specific methyltransferase enhancer of zeste homologue 2 (EZH2) is the catalytic subunit of the repressive complex Polycomb repressive complex 2. EZH2 is typically implicated in transcriptional silencing, but it can also activate gene expression. Here, we show that EZH2 contains three adjacent transactivation domains (EZH2TAD) that are recognized by the TAZ2 domain of the transcriptional coactivator and acetyltransferase p300 (p300TAZ2). Binding interfaces identified by chemical shift perturbations in NMR experiments, measurements of binding affinities, and analysis of the complex formation by mass photometry demonstrate that each EZH2TAD can be concomitantly bound by a separate p300TAZ2. Interaction of EZH2TADs with p300TAZ2 stimulates H3K18- and H3K27-specific acetyltransferase activity of p300. We show that in 22Rv1 prostate cancer cells, EZH2 occupies a large set of gene loci lacking H3K27me3, and these non-canonical genomic sites are instead co-occupied by p300, RNA Polymerase II and BRD4 and are rich in histone marks associated with transcriptional activation. Our findings shed light on the potential basis for such a high degree of genetic co-localization through the direct association of p300TAZ2 with EZH2TADs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Colorado School of Medicine, Aurora CO 80045, U.S.A.
- Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham NC 27710, U.S.A.
- Department of Pathology, Duke University School of Medicine, Durham NC 27710, U.S.A.
- Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, U.S.A.
- Maisonneuve-Rosemont Hospital Research Center, Montréal, Québec H1T 2M4, Canada.
- Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora CO 80045, U.S.A.
ORCID-Profile: Tatiana G Kutateladze
Förderung
- NIGMS NIH HHS
- NINDS NIH HHS
- NCI NIH HHS
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Becht, D. C., Biswas, S., Xu, C., Xuan, H., Khalil, M., Cai, L., Musselman, C. A., Liu, X., Affar, E. B., Shi, X., Wang, G. G., & Kutateladze, T. G. (2025). Multiple transactivation domains of EZH2 bind to the TAZ2 domain of p300 and stimulate the acetyltransferase function of p300. Biochemical Journal. https://doi.org/10.1042/bcj20253037
Vancouver
Becht DC, Biswas S, Xu C, Xuan H, Khalil M, Cai L, et al. Multiple transactivation domains of EZH2 bind to the TAZ2 domain of p300 and stimulate the acetyltransferase function of p300. Biochemical Journal. 2025. doi:10.1042/bcj20253037
BibTeX
@article{Becht2025,
author = {Becht, Dustin C and Biswas, Soumi and Xu, Chenxi and Xuan, Hongwen and Khalil, Moustafa and Cai, Ling and Musselman, Catherine A and Liu, Xin and Affar, El Bachir and Shi, Xiaobing and Wang, Gang Greg and Kutateladze, Tatiana G},
title = {Multiple transactivation domains of EZH2 bind to the TAZ2 domain of p300 and stimulate the acetyltransferase function of p300},
journal = {Biochemical Journal},
year = {2025},
doi = {10.1042/bcj20253037}
}
EUVIMED